Latanoprost SR is under clinical development by Peregrine Ophthalmic and currently in Phase I for Unspecified Ophthalmological Disorders.

Zinpentraxin alfa is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Crohn's Disease (Regional Enteritis).

Health care professionals involved in the care of infants are in an ideal position to identify and to educate families, the public, and other health care professionals about the risk factors ...

Identifying risk factors is an important first step in preventing SBS. A combination of infant, caregiver, social, and environmental risks interact and play a role. Depression, anxiety, and ...